Nanjing Red SunLtd Past Earnings Performance
Past criteria checks 0/6
Nanjing Red SunLtd's earnings have been declining at an average annual rate of -19.8%, while the Chemicals industry saw earnings growing at 7.9% annually. Revenues have been declining at an average rate of 1.9% per year.
Key information
-19.8%
Earnings growth rate
-19.9%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -1.9% |
| Return on equity | -36.3% |
| Net Margin | -11.4% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses Breakdown
How Nanjing Red SunLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 3,331 | -380 | 527 | 296 |
| 31 Dec 23 | 3,232 | -389 | 532 | 295 |
| 30 Sep 23 | 3,719 | -190 | 518 | 164 |
| 30 Jun 23 | 4,566 | 133 | 541 | 225 |
| 31 Mar 23 | 5,659 | 438 | 556 | 272 |
| 01 Jan 23 | 6,440 | 732 | 624 | 285 |
| 30 Sep 22 | 7,023 | -2,835 | 637 | 304 |
| 30 Jun 22 | 6,195 | -3,157 | 630 | 239 |
| 31 Mar 22 | 5,351 | -3,461 | 643 | 205 |
| 01 Jan 22 | 4,683 | -3,744 | 555 | 168 |
| 30 Sep 21 | 4,090 | -213 | 526 | 147 |
| 30 Jun 21 | 3,989 | -190 | 485 | 142 |
| 31 Mar 21 | 4,147 | -139 | 482 | 134 |
| 31 Dec 20 | 4,022 | -154 | 473 | 142 |
| 30 Sep 20 | 3,476 | -535 | 732 | 126 |
| 30 Jun 20 | 4,044 | -524 | 764 | 124 |
| 31 Mar 20 | 4,117 | -453 | 727 | 114 |
| 31 Dec 19 | 4,614 | -340 | 767 | 108 |
| 30 Sep 19 | 5,758 | 368 | 586 | 94 |
| 30 Jun 19 | 5,696 | 501 | 579 | 98 |
| 31 Mar 19 | 5,728 | 554 | 628 | 106 |
| 31 Dec 18 | 5,908 | 637 | 638 | 109 |
| 30 Sep 18 | 5,665 | 753 | 613 | 133 |
| 30 Jun 18 | 5,409 | 749 | 554 | 159 |
| 31 Mar 18 | 5,261 | 759 | 584 | 123 |
| 31 Dec 17 | 5,072 | 714 | 550 | 96 |
| 30 Sep 17 | 4,112 | 609 | 475 | 59 |
| 30 Jun 17 | 3,806 | 420 | 515 | 0 |
| 31 Mar 17 | 3,903 | 256 | 463 | 0 |
| 31 Dec 16 | 3,538 | 126 | 452 | 0 |
| 30 Sep 16 | 3,397 | 1 | 389 | 0 |
| 30 Jun 16 | 3,418 | 64 | 382 | 0 |
| 31 Mar 16 | 4,006 | 129 | 363 | 0 |
| 31 Dec 15 | 4,557 | 182 | 360 | 0 |
| 30 Sep 15 | 6,083 | 249 | 411 | 0 |
| 30 Jun 15 | 6,819 | 315 | 403 | 0 |
| 31 Mar 15 | 6,730 | 380 | 424 | 0 |
| 31 Dec 14 | 6,812 | 427 | 414 | 0 |
| 30 Sep 14 | 7,320 | 506 | 394 | 0 |
| 30 Jun 14 | 7,259 | 496 | 393 | 0 |
| 31 Mar 14 | 7,285 | 434 | 350 | 0 |
| 31 Dec 13 | 7,241 | 372 | 329 | 0 |
| 30 Sep 13 | 7,244 | 332 | 291 | 0 |
| 30 Jun 13 | 7,228 | 308 | 271 | 0 |
Quality Earnings: 000525 is currently unprofitable.
Growing Profit Margin: 000525 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 000525 is unprofitable, and losses have increased over the past 5 years at a rate of 19.8% per year.
Accelerating Growth: Unable to compare 000525's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 000525 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-16.4%).
Return on Equity
High ROE: 000525 has a negative Return on Equity (-36.31%), as it is currently unprofitable.